Eating certain foods or supplements like L-citrulline or nitrate-rich vegetables can help your body make more nitric oxide, a molecule that helps your blood vessels relax and work better.
Claim Context
Dietary precursors such as L-citrulline and inorganic nitrate enhance endogenous nitric oxide synthesis by providing substrates for the L-arginine-nitric oxide synthase pathway and the nitrate-nitrite-NO pathway.
The verb 'enhance' is used, which implies a direct and certain increase in nitric oxide synthesis, suggesting causation rather than possibility or association.
“They are in essence trying to supply more of the raw materials of which the body creates nitric oxide.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (5)
Community contributions welcome
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
Mechanisms of the protective effects of nitrate and nitrite in cardiovascular and metabolic diseases.
Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway
The role of inorganic nitrate and nitrite in CVD
Contradicting (1)
Community contributions welcome
Oral citrulline does not affect whole body protein metabolism in healthy human volunteers: results of a prospective, randomized, double-blind, cross-over study.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Directly tests whether oral supplementation with L-citrulline and inorganic nitrate increases endogenous nitric oxide levels compared to placebo, measured via plasma nitrite/nitrate, exhaled NO, or vascular reactivity.
Double-blind, placebo-controlled RCT in 50 healthy adult humans; intervention group receives 6g L-citrulline + 500mg sodium nitrate daily for 4 weeks; control group receives matched placebo; primary outcome: fasting plasma nitrite/nitrate concentration; secondary outcomes: flow-mediated dilation (FMD) and urinary nitrate excretion; duration: 4 weeks.
Determines whether L-citrulline and nitrate are directly incorporated into the NO synthesis pathways using isotopic labeling.
Crossover RCT in 20 healthy adults; each participant receives 13C-labeled L-citrulline and 15N-labeled sodium nitrate on separate days; plasma and urine samples analyzed for labeled NO metabolites using mass spectrometry; comparator: unlabeled placebo; duration: 2 washout periods of 7 days between interventions.
Establishes whether increasing doses of L-citrulline and nitrate produce graded increases in NO synthesis.
Single-blind, dose-escalation RCT in 30 healthy adults; four arms: placebo, low-dose L-citrulline (2g), medium-dose L-citrulline (6g), and high-dose nitrate (800mg); all administered daily for 14 days; primary outcome: change in plasma nitrite concentration; secondary: endothelial function via FMD; duration: 14 days per dose level with 7-day washout.
Confirms that L-citrulline and nitrate directly stimulate NO production in human vascular cells via the specified pathways.
In vitro exposure of primary human aortic endothelial cells to graded concentrations of L-citrulline (0–1000 µM) and sodium nitrate (0–500 µM); NO production measured via DAF-FM fluorescence; pathway inhibition via NOS inhibitors (L-NAME) and nitrite reductase blockers; comparator: untreated cells; duration: 24–48 hours.
Correlates habitual intake of L-citrulline- and nitrate-rich foods with endogenous NO levels in free-living populations.
Prospective cohort of 500 adults; dietary intake assessed via 7-day food diaries and validated FFQs; plasma nitrite/nitrate and FMD measured at baseline and 12 months; adjusts for confounders (smoking, BMI, medication); duration: 12 months.